Cormorant Asset Management LLC 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-27 4:15 pm Purchase | 2022-12-14 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management LLC | 2,762,115 5.070% | 750,000 (+37.27%) | Filing |
| 2022-02-14 3:06 pm Sale | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management LLC | 2,012,115 4.290% | -452,432 (-18.36%) | Filing |
| 2021-02-16 3:10 pm Sale | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management LLC | 2,464,547 6.570% | -49,998 (-1.99%) | Filing |
| 2020-06-26 4:17 pm Purchase | 2020-06-16 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management LLC | 2,514,545 6.700% | 2,514,545 (New Position) | Filing |